Arrowhead Pharmaceuticals (NASDAQ: ARWR) revenue
Arrowhead Pharmaceuticals reported revenue of $829.4m for fiscal 2025, 23,258.2% more than in fiscal 2024 ($3.6m). Since fiscal 2016 its revenue has grown by 523,763.0%, an average growth of 159.0% a year.
Fiscal 2025 is the highest of the 10 fiscal years on record for Arrowhead Pharmaceuticals. The biggest drop was in fiscal 2024, −98.5%.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Revenue by fiscal year
| Fiscal year | Revenue | Change | Operating profit | Operating margin |
|---|---|---|---|---|
| 2025 | $829.4m | +23,258.2% | $98.3m | 11.9% |
| 2024 | $3.6m | −98.5% | −$601.1m | −16,927.1% |
| 2023 | $240.7m | −1.0% | −$205.0m | −85.2% |
| 2022 | $243.2m | +75.9% | −$178.5m | −73.4% |
| 2021 | $138.3m | +57.2% | −$149.0m | −107.8% |
| 2020 | $88.0m | −47.9% | −$93.2m | −105.9% |
| 2019 | $168.8m | +945.7% | $61.2m | 36.3% |
| 2018 | $16.1m | −48.6% | −$55.9m | −346.5% |
| 2017 | $31.4m | +19,736.5% | −$37.0m | −117.8% |
| 2016 | $0.2m | — | −$81.7m | −51,627.1% |
The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Arrowhead Pharmaceuticals revenue compared with its sector
By revenue for its latest fiscal year, Arrowhead Pharmaceuticals ranks 164th of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; Arrowhead Pharmaceuticals, 23,258.2%.
| Rank | Company | Revenue | Revenue growth |
|---|---|---|---|
| 162nd | Harmony Biosciences | $868.5m | 21.5% |
| 163rd | Varex Imaging | $844.6m | 4.1% |
| 164th | Arrowhead Pharmaceuticals | $829.4m | 23,258.2% |
| 165th | Myriad Genetics | $824.5m | −1.6% |
| 166th | Orthofix Medical | $822.3m | 2.9% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the revenue of Arrowhead Pharmaceuticals
- How much revenue did Arrowhead Pharmaceuticals make in fiscal 2025?
- Arrowhead Pharmaceuticals reported revenue of $829.4m for fiscal 2025, compared with $3.6m in fiscal 2024.
- How much has the revenue of Arrowhead Pharmaceuticals grown?
- Between fiscal 2016 and fiscal 2025 it went from $0.2m to $829.4m: 523,763.0% more, an average growth of 159.0% a year.
- What was the best year for revenue at Arrowhead Pharmaceuticals?
- Of its last 10 fiscal years, fiscal 2025, with $829.4m.
- Where does Arrowhead Pharmaceuticals rank in its sector by revenue?
- It ranks 164th of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
- Where do the figures for Arrowhead Pharmaceuticals come from?
- From the annual report (Form 10-K) that Arrowhead Pharmaceuticals files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Arrowhead Pharmaceuticals files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on Arrowhead Pharmaceuticals: the Arrowhead Pharmaceuticals page · annual accounts · net income · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.